Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), and Merck (NYSE: MRK). Alphabet's problem isn't its financial results; in that ...

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis ...

The first phase is compulsory for all candidates, while the second is optional. However, students who skip three or more ...

The first ceremonial shovels of dirt were turned Monday morning. The real dirt moving is underway. Officials expect it will ...

A specially designed 21-seater air-conditioned electric cruise vessel for the tour is currently under construction and ...